264 related articles for article (PubMed ID: 15758666)
1. Pathophysiology of cholangiopathies.
Strazzabosco M; Fabris L; Spirli C
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S90-S102. PubMed ID: 15758666
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of the intrahepatic biliary epithelium.
Strazzabosco M; Spirlí C; Okolicsanyi L
J Gastroenterol Hepatol; 2000 Mar; 15(3):244-53. PubMed ID: 10764023
[TBL] [Abstract][Full Text] [Related]
3. The intrahepatic cholangiopathies.
Birnbaum A; Suchy FJ
Semin Liver Dis; 1998; 18(3):263-9. PubMed ID: 9773426
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of the intrahepatic biliary epithelium.
Glaser S; Francis H; Demorrow S; Lesage G; Fava G; Marzioni M; Venter J; Alpini G
World J Gastroenterol; 2006 Jun; 12(22):3523-36. PubMed ID: 16773709
[TBL] [Abstract][Full Text] [Related]
5. Pathology and pathogenesis of intrahepatic bile duct loss.
Nakanuma Y; Tsuneyama K; Harada K
J Hepatobiliary Pancreat Surg; 2001; 8(4):303-15. PubMed ID: 11521175
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of novel aspects of biliary pathophysiology.
Marzioni M; Saccomanno S; Candelaresi C; Rychlicki C; Agostinelli L; Trozzi L; De Minicis S; Benedetti A
Dig Liver Dis; 2010 Apr; 42(4):238-44. PubMed ID: 20167547
[TBL] [Abstract][Full Text] [Related]
7. The Cholangiopathies.
Lazaridis KN; LaRusso NF
Mayo Clin Proc; 2015 Jun; 90(6):791-800. PubMed ID: 25957621
[TBL] [Abstract][Full Text] [Related]
8. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.
Fabris L; Fiorotto R; Spirli C; Cadamuro M; Mariotti V; Perugorria MJ; Banales JM; Strazzabosco M
Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):497-511. PubMed ID: 31165788
[TBL] [Abstract][Full Text] [Related]
9. Cholangiocyte pathobiology.
Banales JM; Huebert RC; Karlsen T; Strazzabosco M; LaRusso NF; Gores GJ
Nat Rev Gastroenterol Hepatol; 2019 May; 16(5):269-281. PubMed ID: 30850822
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver.
Alvaro D; Mancino MG; Glaser S; Gaudio E; Marzioni M; Francis H; Alpini G
Gastroenterology; 2007 Jan; 132(1):415-31. PubMed ID: 17241889
[TBL] [Abstract][Full Text] [Related]
11. If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.
Nejak-Bowen K
Gene Expr; 2020 Jun; 20(1):19-23. PubMed ID: 31439080
[TBL] [Abstract][Full Text] [Related]
12. Transport systems in cholangiocytes: their role in bile formation and cholestasis.
Strazzabosco M
Yale J Biol Med; 1997; 70(4):427-34. PubMed ID: 9626763
[TBL] [Abstract][Full Text] [Related]
13. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver.
LeSage GD; Glaser SS; Marucci L; Benedetti A; Phinizy JL; Rodgers R; Caligiuri A; Papa E; Tretjak Z; Jezequel AM; Holcomb LA; Alpini G
Am J Physiol; 1999 May; 276(5):G1289-301. PubMed ID: 10330021
[TBL] [Abstract][Full Text] [Related]
14. Emerging concepts in biliary repair and fibrosis.
Fabris L; Spirli C; Cadamuro M; Fiorotto R; Strazzabosco M
Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G102-G116. PubMed ID: 28526690
[TBL] [Abstract][Full Text] [Related]
15. The crucial role of cholangiocytes in cholangiopathies.
Park SM
Gut Liver; 2012 Jul; 6(3):295-304. PubMed ID: 22844556
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocyte injury and ductopenic syndromes.
Xia X; Demorrow S; Francis H; Glaser S; Alpini G; Marzioni M; Fava G; Lesage G
Semin Liver Dis; 2007 Nov; 27(4):401-12. PubMed ID: 17979076
[TBL] [Abstract][Full Text] [Related]
17. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
Trauner M; Fickert P; Halilbasic E; Moustafa T
Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
[TBL] [Abstract][Full Text] [Related]
18. Development of the bile ducts: essentials for the clinical hepatologist.
Strazzabosco M; Fabris L
J Hepatol; 2012 May; 56(5):1159-1170. PubMed ID: 22245898
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.
DeMorrow S; Meng F; Venter J; Leyva-Illades D; Francis H; Frampton G; Pae HY; Quinn M; Onori P; Glaser S; McDaniel K; Mancinelli R; Gaudio E; Alpini G; Franchitto A
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(3):G250-7. PubMed ID: 23703654
[TBL] [Abstract][Full Text] [Related]
20. New insights on the molecular and cell biology of human cholangiopathies.
Alvaro D; Mancino MG
Mol Aspects Med; 2008; 29(1-2):50-7. PubMed ID: 18230407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
